Product Information
BUPROPION HCL SR 200 MG TABLET is a generic product labeled by Camber Pharmaceuticals Inc., priced at $0.1087 per EA under NDC 31722006860. Its NADAC has been published 131 times since Feb 21, 2024.
FDA first approved this application on May 31, 2023. Its Orange Book therapeutic-equivalence code is AB1 — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
200 mg/1
Manufacturer
Camber Pharmaceuticals Inc.NDC
31722006860
Classification
Generic
Dosage Form
TABLET, EXTENDED RELEASE
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
BUPROPION HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA216800FDA Approved
5/31/2023
TE Code
AB1
On Market Since
5/31/2023
Pharmacological Classes
Price Statistics
The NADAC for BUPROPION HCL SR 200 MG TABLET has been published 131 times since Feb 21, 2024, and over the history we have for it it has declined 22.3%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1087 per EA |
|---|---|
| All-time high | $0.1646 (Jun 11, 2025) |
| All-time low | $0.1002 (Nov 19, 2025) |
| 52-week high | $0.1380 |
| 52-week low | $0.1002 |
| Median price | $0.1150 |
| Average price | $0.1228 |
| Largest weekly change | +25.5% (Jun 19, 2024) |
| Weeks tracked | 131 |
| Tracking since | Feb 21, 2024 |
Generic Alternatives
The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of BUPROPION HCL SR 200 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for BUPROPION HCL SR 200 MG TABLET, manufactured by Camber Pharmaceuticals Inc., is $0.1087 per EA (NDC 31722006860), effective Aug 19, 2026.
How has the price of BUPROPION HCL SR 200 MG TABLET changed over time?
Over the history we have for it, the NADAC for BUPROPION HCL SR 200 MG TABLET has declined 22.3%. It has been tracked across 131 weekly CMS publications since Feb 21, 2024.
What are the highest and lowest recorded NADAC prices for BUPROPION HCL SR 200 MG TABLET?
Since Feb 21, 2024, the NADAC for BUPROPION HCL SR 200 MG TABLET has ranged from a low of $0.1002 (Nov 19, 2025) to a high of $0.1646 (Jun 11, 2025), with a median of $0.1150 per EA.
Are there cheaper alternatives to BUPROPION HCL SR 200 MG TABLET?
2 manufacturers publish a NADAC-priced product with the same active ingredient and strength as BUPROPION HCL SR 200 MG TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures BUPROPION HCL SR 200 MG TABLET?
BUPROPION HCL SR 200 MG TABLET (NDC 31722006860) is labeled by Camber Pharmaceuticals Inc., and CMS classifies it as a generic product.